Corteva (CTVA)

• Market cap: $42.8B
• 1 day: 1.12%
• 5 days: 8.95%
• 1 month: 6.40%
• 3 months: 5.72%
• 6 months: 12.21%
• Year to date: 10.61%
• 1 year: 38.98%
• 5 years: 120.21%
• 10 years: 114.90%
• Sector: Consumer Staples
• Industry: Agriculture Production Crops

About: Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.

Employees: 22,500

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

30% more call options, than puts

Call options by funds: $78.3M | Put options by funds: $60.3M

25% more funds holding in top 10

Funds holding in top 10: 12 [Q2] → 15 (+3) [Q3]

7% more capital invested

Capital invested by funds: $31.8B [Q2] → $34.2B (+$2.33B) [Q3]

0.74% less ownership

Funds ownership: 84.7% [Q2] → 83.96% (-0.74%) [Q3]

2% less first-time investments, than exits

New positions opened: 96 | Existing positions closed: 98

2% less funds holding

Funds holding: 1,223 [Q2] → 1,204 (-19) [Q3]

16% less repeat investments, than reductions

Existing positions increased: 399 | Existing positions reduced: 477

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $62 1% downside
• Avg. target: $69 11% upside
• High target: $73 17% upside

8 analyst ratings

• positive: 7 88%
• neutral: 1 13%
• negative: 0 0%

UBS Joshua Spector 59% 1-year accuracy 19 / 32 met price target	17% upside $73	Buy Maintained	10 Jan 2025
Keybanc Aleksey Yefremov 37% 1-year accuracy 41 / 111 met price target	9% upside $68	Overweight Maintained	10 Jan 2025
RBC Capital Arun Viswanathan 29% 1-year accuracy 20 / 70 met price target	17% upside $73	Outperform Maintained	19 Dec 2024
Citigroup Patrick Cunningham 41% 1-year accuracy 13 / 32 met price target	11% upside $69	Buy Maintained	18 Dec 2024
Wells Fargo Richard Garchitorena 80% 1-year accuracy 8 / 10 met price target	8% upside $67	Overweight Maintained	20 Nov 2024